ZonMW Enabling Technologies Hotels 4th call for projects
Deadline: 29 August 2017, 14:00
The main goal of the programme Enabling Technologies Hotels is to provide wider access for researchers in the Netherlands to high-end technologies and the connected expertise and infrastructure. This is realized within the framework of public private partnerships (PPP) with the following aims:
- Facilitate the dissemination of unique technological expertise in the Netherlands to other research groups/institutions/Small-Medium Enterprises (SMEs) that have not worked with that technology before.
- To encourage the use of advanced life sciences technologies in public-private partnerships and to stimulate novel interactions among research groups and technology providers and thereby contribute to the advancement of the used technology.
- Propagate the use of data stewardship and data integration principles, methods and standards in advanced multi-technology research projects.
ZonMW Antibiotica Resistentie (ABR)
Deadline: 5 September 2017 (second round)
The Antibiotic Resistance programme funds research designed to help fight antibiotic resistance and/or identify points of action for the development of new antibiotics or interventions. The ambition is to reduce antibiotic resistance within 5 years following publication of project results.
This is a call for submission of grant applications dealing with antibiotic resistance. It is the second call within the programme ‘Antibiotic Resistance’. Only research within the following research areas is eligible for funding in this round: a. Mechanisms for acquiring and transmitting antibacterial resistance in different environments e.g., patients, hospitals, farms, nature, etc,. b. Appropriate (use of) diagnostics c. Optimising antibiotic dosage and prudent use Note: Research on new targets and alternatives for antibiotics will NOT be funded in this round. NWO TTW (in Dutch) has recently launched a new research programme on development of antibiotics and alternatives.
The first round closed on 27 June for pre-proposals.
Deadline: 21 September 2017, 14:00 Only proposals that have taken part in the pre-proposal phase, will be accepted in the full proposal phase.
Read the news item on the NACTAR Call here.
NADP will engage with EU and global initiatives in order to achieve synergies and focus on strategic priorities These include among others :
- A new EU strategy on AMR, plus the ongoing work under the IMI Innovative Medicines Initiative
- G7/G20 initiative on combatting AMR
- World Economic Forum: “Antibiotic resistance is the next great global challenge – we must act now”
- The creation of CARB-X was prioritized in the 2015 US National Action Plan on Combating Antibiotic-Resistant Bacteria (CARB), which called for a biopharmaceutical accelerator to spur pre-clinical product development.
- The Global Antibiotic Research and Development Partnership (GARDP) was established in May 2016 as a joint initiative by the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi).
- WHO Global action plan on AMR, including prioritisation of pathogens
- WHO review of the antibiotics chapter of the WHO Essential Medicines list